Éric DesRosiers
Präsident bei Northern Therapeutics, Inc.
Aktive Positionen von Éric DesRosiers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Le Devoir, Inc.
 Le Devoir, Inc. Publishing: NewspapersConsumer Services Le Devoir, Inc. operates as an online newspaper. It publishes articles talk about history, politics, culture, society issues, economy, arts, sports, and sciences. The company was founded by Henri Bourassa on January 10, 1910 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 13.12.2017 | - |
Séminaire des Trois-Rivières
 Séminaire des Trois-Rivières Other Consumer ServicesConsumer Services Séminaire des Trois-Rivières provides education services. It offers library, arts, sports and residence. The company is headquartered in Trois-Rivières, Canada. | Direktor/Vorstandsmitglied | - | - |
Northern Therapeutics, Inc.
 Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | Präsident | - | - |
Karriereverlauf von Éric DesRosiers
Ehemalige bekannte Positionen von Éric DesRosiers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KLOX TECHNOLOGIES INC | Corporate Officer/Principal | - | - |
Apotex Corp.
 Apotex Corp. Pharmaceuticals: MajorHealth Technology Apotex Corp. is a generic pharmaceuticals company, which offers generics, innovative molecules, and biotechnology products. The company was founded in 1999 and is headquartered in Weston, FL. | Corporate Officer/Principal | 01.01.1994 | - |
| BIOSYNTECH, INC. | Geschäftsführer | 01.01.2000 | - |
Ausbildung von Éric DesRosiers
| University of Ottawa | Undergraduate Degree |
| University of Montréal | Doctorate Degree |
Statistik
International
| Kanada | 8 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOSYNTECH, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
KLOX Technologies, Inc.
 KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |
Apotex Corp.
Apotex Corp. Pharmaceuticals: MajorHealth Technology Apotex Corp. is a generic pharmaceuticals company, which offers generics, innovative molecules, and biotechnology products. The company was founded in 1999 and is headquartered in Weston, FL. | Health Technology |
Le Devoir, Inc.
Le Devoir, Inc. Publishing: NewspapersConsumer Services Le Devoir, Inc. operates as an online newspaper. It publishes articles talk about history, politics, culture, society issues, economy, arts, sports, and sciences. The company was founded by Henri Bourassa on January 10, 1910 and is headquartered in Montreal, Canada. | Consumer Services |
Séminaire des Trois-Rivières
Séminaire des Trois-Rivières Other Consumer ServicesConsumer Services Séminaire des Trois-Rivières provides education services. It offers library, arts, sports and residence. The company is headquartered in Trois-Rivières, Canada. | Consumer Services |
Northern Therapeutics, Inc.
Northern Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Northern Therapeutics, Inc. operate as a biotechnology company. It develops a novel method for selective gene transfer and regenerative cell therapy targeting the pulmonary vasculature with the hope of repairing damaged lung tissues in a number of respiratory and cardiopulmonary conditions, including PAH, Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis and Emphysema. The company was founded in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Börse
- Insiders
- Éric DesRosiers
- Erfahrung
